Board Meetings for WOCKPHARMA
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| WOCKPHARMA | Wockhardt Limited | 04 May 2026 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 04-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Fund raising. | |
| WOCKPHARMA | Wockhardt Limited | 04 May 2026 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended March 31, 2026 and Fund Raising | |
| WOCKPHARMA | Wockhardt Limited | 10 Feb 2026 | Financial Results | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th February, 2026, inter-alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and nine months ended 31st December, 2025. | |
| WOCKPHARMA | Wockhardt Limited | 10 Feb 2026 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| WOCKPHARMA | Wockhardt Limited | 03 Nov 2025 | Financial Results | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of theCompany will be held on Monday, 3rd November, 2025, inter-alia, to consider and approve theUn-audited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30th September, 2025 | |
| WOCKPHARMA | Wockhardt Limited | 03 Nov 2025 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2025 . | |
| WOCKPHARMA | Wockhardt Limited | 08 Aug 2025 | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | Board Meeting Intimation | |
| WOCKPHARMA | Wockhardt Limited | 08 Aug 2025 | Financial Results | Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Friday, 8th August, 2025, inter-alia, to consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June, 2025. | |
| WOCKPHARMA | Wockhardt Limited | 29 May 2025 | Financial Results/Fund Raising | Pursuant to Regulation 29(1) (a) and (d) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, 29th May, 2025, inter-alia, to consider and approve the following: (i)The Audited Financial Results (Standalone & Consolidated) of the Company for the quarter and financial year ended 31st March, 2025; and (ii)Raising of funds by issue of Equity Shares, Equity Shares through depository receipt including Global Depository Receipts ( GDRs ), American Depository Receipts ( ADRs ), Foreign Currency Convertible Bonds ( FCCBs ), Fully Convertible Debentures ( FCDs ), Partly Convertible Debentures ( PCDs ) Optionally Convertible Debentures ( OCDs ), and / or Non-Convertible Debentures ( NCDs ) and / or other securities convertible into Equity Shares with or without warrants and/ or convertible preference shares or any security convertible into Equity Shares, or any combination of such securities in one or more tranches by way of one or more public and/ or private offerings including qualified institutional placement and/or on preferential allotment basis or any combination thereof or any other method as may be permitted under applicable law, subject to consent of Shareholders at the ensuing Annual General Meeting and such approvals and compliance as may be required, and to approve ancillary actions for the above mentioned fund raising | |
| WOCKPHARMA | Wockhardt Limited | 29 May 2025 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 29-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Fund raising. | |
| WOCKPHARMA | Wockhardt Limited | 07 Feb 2025 | Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited | |
| WOCKPHARMA | Wockhardt Limited | 07 Feb 2025 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 07-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| WOCKPHARMA | Wockhardt Limited | 13 Nov 2024 | Financial Results | Intimation of the Meeting of Board of Directors of Wockhardt Limited | |
| WOCKPHARMA | Wockhardt Limited | 13 Nov 2024 | Board Meeting Intimation | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . | |
| WOCKPHARMA | Wockhardt Limited | 09 Aug 2024 | WOCKHARDT LIMITED has informed the Exchange about Board Meeting to be held on 09-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation |
Showing page 1 of 8 (115 total items)